RxDoctor Payments Data

Haley Moss

Family · Poplar Bluff, MONPI 1811668460

Payments from drug & device makers

$4,418in general payments, 2019–2025

Across 240 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$542
  • Lilly USA, LLC$341
  • LEO Pharma Inc.$338
  • Novartis$277
  • Sun Pharmaceutical Industries Inc.$229
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$4,35899%
  • Education$601%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,418 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$150,930
Medicare patients
488
Services billed
2,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab38$337,048
SkyriziRisankizumab-Rzaa14$313,788
Dupixent SyringeDupilumab33$136,645
Cosentyx Sensoready (2 Pens)Secukinumab12$87,335
Dupixent PenDupilumab11$42,499
Fluorouracil47$4,255
Clobetasol Propionate45$1,534
Doxycycline Hyclate78$1,287
Ketoconazole108$1,099
Mometasone Furoate68$947
Tretinoin15$704
Triamcinolone Acetonide103$571
CiclopiroxCiclopirox Olamine18$361
Mupirocin32$254

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSkyrizi$1,282$313,78814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.

Other family in Poplar Bluff

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →